<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372214/" ref="ordinalpos=42&amp;ncbi_uid=4416011&amp;link_uid=PMC3372214" image-link="/pmc/articles/PMC3372214/figure/F1/" class="imagepopup">Fig 1.  From: Hepatitis C Virus Activates the mTOR/S6K1 <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> in Inhibiting IRS-1 Function for Insulin Resistance. </a></div><br /><div class="p4l_captionBody">Simplified schematic presentation of HCV genotype 2a-mediated blocking of the insulin signaling pathway. We suggested previously that HCV infection upregulates Ser-312 phosphorylation of IRS-1 and impairs the Akt signaling pathway by modulation of Ser/Thr phosphorylation in the upstream insulin signaling pathway (11). Analysis of the downstream signaling pathway reveals that HCV further downregulates tumor suppressor TSC1/TSC2, resulting in an upregulation of Rheb. This results in downstream activation of mTOR and S6K1, which in turn acts as a negative regulator of IRS-1, causing insulin resistance. Directions of solid arrows on the side indicate up- or downregulation of specific signaling molecules.</div></div>